Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?

Annals of Surgical Oncology

Volumn 15, Issue 10, 2008, Pages 2728-2733

  Chung, Alice ^a   Yu, Jeanne ^a   Stempel, Michelle ^a   Patil, Sujata ^a   Cody III, Hiram ^a   Montgomery, Leslie ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

10 rule; Isotope; Mapping; Sentinel lymph node biopsy

Indexed keywords

EOSIN; HEMATOXYLIN; ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SCINTISCANNING; CANCER STAGING; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EX VIVO STUDY; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALIDITY; RADIATION MEASUREMENT; SENTINEL LYMPH NODE BIOPSY; STAINING; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; COLORING AGENTS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 51649131591     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0050-8     Document Type: Article

References (28)

1. ADK Hill KN Tran T Akhurst 1999 Lessons learned from 500 cases of lymphatic mapping for breast cancer Ann Surg 229 528 35
2. CE Cox S Pendas JM Cox 1998 Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer Ann Surg 227 645 53
3. KM McMasters TM Tuttle DJ Carlson 2000 Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used J Clin Oncol 18 2560 6
4. O'Hea BJ, Hill ADK, El-Shirbiny et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan Kettering Cancer Center. J Am Coll Surg 1998;186:423-7
5. G Canavese M Gipponi A Catturich 2000 Sentinel node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery J Surg Oncol 74 61 8
6. JY Bobin C Spirito S Isaac 2000 Lymph node mapping and axillary sentinel lymph node biopsy in 243 invasive breast cancers with no palpable nodes. The Lyon Sud Hospital experience Ann Chir 125 861 70
7. HS Cody J Fey T Akhurst 2001 Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures Ann Surg Oncol 8 13 9
8. AM Derossis J Fey H Yeung 2001 A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer J Am Coll Surg 193 473 8
9. Z Radaovanovic A Golubovic A Plzak 2004 Blue dye versus blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer Eur J Surg Oncol 30 913 7
10. T Kim AE Giuliano GH Lyman 2006 Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis Cancer 106 4 16
11. DM Morton PJ Bostick 1999 Will the true sentinel node please stand? Ann Surg Oncol 6 12 4
12. RCG Martin MJ Edwards SL Wong 2000 Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study Surgery 128 139 44
13. MD McCarter H Yeung J Fey 2001 The breast cancer patient with multiple sentinel nodes: when to stop? J Am Coll Surg 192 692 7
14. JJ Albertini GH Lyman C Cox 1996 Lymphatic mapping and sentinel node biopsy in the patient with breast cancer JAMA 276 1818 22
15. D Krag D Weaver T Ashikaga 1998 The sentinel node in breast cancer N Eng J Med 339 941 6
16. U Veronesi G Paganelli V Galimberti 1997 Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes Lancet 349 1864 7
17. RCG Martin J Fey H Yeung 2001 Highest isotope count does not predict sentinel node positivity in all breast cancer patients Ann Surg Oncol 8 592 7
18. JA Crossin AC Johnson PB Stewart 1998 Gamma-probe-guided resection of the sentinel lymph node in breast cancer Am Surg 64 666 8
19. KN McMasters DS Reintgen MI Ross 2001 Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol 8 192 7
20. SL Wong MJ Edwards C Chao 2001 Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate J Am Coll Surg 192 684 9
21. XY Song XM Yuan WJ Chen 2007 Different criteria for radioactive sentinel lymph nodes has different impact on sentinel node biopsy in breast cancer patients J Surg Oncol 95 635 9
22. JS Jeruss KK Hunt Y Xing 2006 Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective? Cancer 107 2328 36
23. DM Agnese SF Abdessalan WE Burak 2003 Cost-effectiveness of sentinel lymph node biopsy in thin melanomas Surgery 134 542 8
24. I Langer U Guller G Berclaz 2007 Morbidity of sentinel lymph node biopsy alone versus SLN ans completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients Ann Surg 245 452 61
25. HM Kroon L Lowe S Wong 2007 What is a sentinel node? Re-evaluating the 10% rule for sentinel lymph node biopsy in melanoma J Surg Oncol 95 623 8
26. RCG Martin A Chapgar CR Scoggins 2005 Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer Ann Surg 241 1005 15
27. PJ Borgstein R Pijpers EF Comans 1998 Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection J Am Coll Surg 186 275 83
28. A Goyal RG Newcombe A Chhabra 2006 Factors affecting failed localization and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase Breast Can Res Treat 99 203 8